This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Simdax
  • /
  • Levosimendan pharmacokinetics in children (LevoCor...
Clinical trial

Levosimendan pharmacokinetics in children (LevoCorKids)

Read time: 2 mins
Last updated:1st Nov 2012
Identifier: NCT01704131
Levosimendan is a drug used in patients with heart failure and has several advantages over other heart failure drugs. A lot of research has been done with levosimendan in adults, and the way the body handles the drug (pharmacokinetics) and responds to the drug (pharmacodynamics) are well established. But, in children this information is lacking despite the fact that levosimendan is increasingly used in children of all ages. The investigators aim to describe which levosimendan dose leads to which drug levels in children of different ages.
Category Value
Date last updated at source 2015-04-01
Study type(s) Observational study
Expected enrolment 36
Study start date 2012-11-01
Estimated primary completion date 2016-11-30

View full details